Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk: A Review of the Literature.

Roose SP, Rutherford BR.

J Clin Psychopharmacol. 2016 Dec;36(6):704-709.

PMID:
27684291
2.

Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database.

Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J.

BMJ. 2016 Mar 22;352:i1350. doi: 10.1136/bmj.i1350.

3.

Can Antidepressant Drug Impact on Blood Pressure Level in Patients with Psychiatric Disorder and Hypertension? A Randomized Trial.

Razavi Ratki SK, Seyedhosseini S, Valizadeh A, Rastgoo T, Tavakkoli R, Golabchi A, Ghashghaei FE, Nemayandeh SM, Boroomand A, Shirinzade A.

Int J Prev Med. 2016 Jan 25;7:26. doi: 10.4103/2008-7802.174891. eCollection 2016.

4.

Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study.

Noordam R, Aarts N, Leening MJ, Tiemeier H, Franco OH, Hofman A, Stricker BH, Visser LE.

Eur J Clin Pharmacol. 2016 Feb;72(2):211-8. doi: 10.1007/s00228-015-1972-2. Epub 2015 Nov 7.

5.

Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis.

Undela K, Parthasarathi G, John SS.

Indian J Pharmacol. 2015 May-Jun;47(3):256-62. doi: 10.4103/0253-7613.157112. Review.

6.

Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.

Andrews PW, Thomson JA Jr, Amstadter A, Neale MC.

Front Psychol. 2012 Apr 24;3:117. doi: 10.3389/fpsyg.2012.00117. eCollection 2012.

7.

Monoamine depletion by reuptake inhibitors.

Hinz M, Stein A, Uncini T.

Drug Healthc Patient Saf. 2011;3:69-77. doi: 10.2147/DHPS.S24798. Epub 2011 Oct 20.

8.

Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E.

CMAJ. 2011 Nov 8;183(16):1835-43. doi: 10.1503/cmaj.100912. Epub 2011 Sep 26.

9.

The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.

Kimmel SE, Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD.

Br J Clin Pharmacol. 2011 Sep;72(3):514-7. doi: 10.1111/j.1365-2125.2011.04008.x.

10.

Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation.

Hinz M, Stein A, Neff R, Weinberg R, Uncini T.

Neuropsychiatr Dis Treat. 2011 Jan 26;7:31-8. doi: 10.2147/NDT.S16270.

11.

Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.

Hamer M, Batty GD, Seldenrijk A, Kivimaki M.

Eur Heart J. 2011 Feb;32(4):437-42. doi: 10.1093/eurheartj/ehq438. Epub 2010 Nov 30. Erratum in: Eur Heart J. 2013 Oct;34(40):3160. David Batty, G [corrected to Batty, G David].

12.

Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Blanchette CM, Simoni-Wastila L, Shaya FT, Orwig D, Noel J, Stuart B.

Cardiol Res Pract. 2009;2009:194528. doi: 10.4061/2009/194528. Epub 2009 Dec 22.

13.

Antidepressant use, depression, and survival in patients with heart failure.

O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR.

Arch Intern Med. 2008 Nov 10;168(20):2232-7. doi: 10.1001/archinte.168.20.2232.

15.

Stress, depression, and coronary artery disease: modeling comorbidity in female primates.

Shively CA, Musselman DL, Willard SL.

Neurosci Biobehav Rev. 2009 Feb;33(2):133-44. doi: 10.1016/j.neubiorev.2008.06.006. Epub 2008 Jun 24. Review.

16.

Supplemental Content

Support Center